Carbonic anhydrase II (CA II) expression is vital to normal osteoclast function. We and others have previously reported induction of CA II messenger RNA (mRNA) expression by 1,25(OH) 2 
A S HEMATOPOIETIC precursors differentiate toward
an osteoclast phenotype, they express proteins vital to osteoclast function (1) . One of these proteins is carbonic anhydrase II (CA II), an enzyme that catalyzes the production of protons, necessary for bone resorption, from CO 2 and H 2 O (2, 3). 1,25(OH) 2 D 3 has previously been shown to stimulate CA II expression in cell culture and avian marrow cultures (4, 5, 6 ) and a vitamin D response element (VDRE) consensus sequence has been identified in the chicken CA II promoter (7) . However, because 1,25(OH) 2 D 3 also is known to promote osteoclast formation, the question remains whether stimulation of CA II expression in marrow culture is due to direct up-regulation of the CA II gene by 1,25(OH) 2 D 3 or whether it arises during the 1,25(OH) 2 D 3 induced program of osteoclastogenesis, which requires the presence of accessory stromal cells.
Regulation of CA II messenger RNA (mRNA) expression has previously been studied in myelomonocytic cell lines (4, 5, 6, 8) . In the myelomonocytic HL-60 cell line and transformed avian myelomonocytes, CA II mRNA expression is increased by PMA and/or 1,25(OH) 2 D 3 (ibid). While these myelomonocytic cell lines are models of colony forming units for granulocytes and macrophages, they do not readily form osteoclasts and may not be a good model for osteoclast differentiation (8, 9) . In addition, CA II expression occurs in the absence of stromal cells that are known to be essential for full expression of the osteoclast phenotype (10) . In avian marrow cells, CA II expression is detected within 24 h of exposure to 1,25(OH) 2 D 3 and increases further as the cells differentiate toward mature, multinucleated osteoclasts (5) . These authors suggest that 1,25(OH) 2 D 3 may be directly increasing transcription of CA II via action on the promoter (ibid) and later demonstrated increased transcription in an avian myelomonocytic cell line (8) . To separate possible effects of 1,25(OH) 2 D 3 on the CA II promoter from the 1,25(OH) 2 D 3 induced differentiation process, we studied CA II mRNA expression during osteoclastogenesis in primary mixed marrow.
This report describes regulation of CA II mRNA expression in mixed murine marrow cultures. CA II mRNA expression was studied in osteoclast precursors at day 4 in culture before fusion. We found that induction of CA II mRNA in precursors is intrinsic to the differentiation pathway toward the osteoclast phenotype and requires physical contact with stromal cells.
Cell culture
Primary marrow culture: 6-to 28-week-old mice were killed by cervical dislocation after CO 2 anesthesia. Femorae and tibiae were aseptically removed and dissected free of adhering tissue. Bone ends were cut off and marrow cavity flushed with ␣-MEM using a 25G needle and marrow cells washed twice with ␣-MEM (11). Cells were cultured in ␣-MEM containing 10% FBS at 2 ϫ 10 6 cells/well in 24-well plates. Twenty-four hours after plating, cultures were treated with 10 nm 1,25(OH) 2 D 3 for 3 days. All cultures were maintained in a humidified atmosphere of 5% CO 2 at 37 C.
Nonadherent marrow cells. Primary marrow cells were incubated with 0.83% NH 4 Cl/Tris-HCl buffer for 5 min to burst red cells, washed, and plated overnight in ␣-MEM with 10% FCS. The nonadherent cells were removed and replated in a 24-well dish at a density of 1 ϫ 10 6 /well. All nonadherent marrow cultures were treated with 2.5% L929 conditioned media to maintain cell viability. These cultures exhibited 99% nonspecific esterase staining and were negative for alkaline phosphatase (data not shown). 
L929 conditioned media
L929 cells were cultured in RPMI media with 10% FCS. Conditioned media was collected from cells grown for 1 week. Macrophage colony stimulating factor (MCSF) levels in the conditioned media were assayed using the MCSF-dependent cell line M-NFS-60 bioassay as described previously (12) .
RT-PCR
RNA was extracted by the method of Chomcynzski (13) . Cells were lysed in 4 m guanidium isothiocyanate, 25 mm sodium citrate, 0.5% sarcosyl, 0.1 m 2-mercaptoethanol, at pH 7. To the lysate was added 1/10 vol of 2 m sodium acetate (pH 4), 1 vol phenol, and 2/10 vol chloroform/ isoamyl alcohol. This mixture was cooled on ice for 15 min and centrifuged 15 min at 4 C. The RNA was precipitated, washed with 75% ethanol, and resuspended in 20 l water containing 40 U RNAsin with 2 mm DTT. A quantity of 0.5 g of the isolated RNA was added to a 10 l RT reaction containing: 2.5 mm deoxy-NTPs, 1 ϫ buffer, 2 m reverse primer, recombinant RNAse H-moloney murine leukemia virus reverse transcriptase, RNAsin, and an RT primer specific for carbonic anhydrase II [CAII RT primer: 5Ј-CGCCAGTTGTCC-3Ј (734 -723)], incubated for 30 min at 37 C. PCR was performed on the 10 l of RT product. PCR: 200 m deoxy-NTPs, 0.5 m of PCR primers, PCR buffer (provided by Perkin-Elmer, Foster City, CA), 1.6 m MgCl 2 , 10 l of RT reaction is heated to 95 C for 2 min and then Taq polymerase added. The forward primer was end-labeled with 32 P-␥-ATP using T 4 kinase to allow visualization and quantitation. Fifteen microliters of of PCR products were run on a 15% acrylamide gel, silver stained, and exposed to a phosphorimager to measure density. Glyceraldehyde dehydrogenase phosphate (GAP) was used as control. Data are expressed as CAII/GAP. The CA II reaction was carried out for 23 cycles, annealing at 56 C. Cycle experiments were carried out to ascertain optimal conditions; CA II RT-PCR product plateaued at 25 cycles, GAP at 23 cycles. PCR conditions were selected for log-phase expansion. Primers: CA II reverse primer: 5Ј-ATCCAGGTCACACATTCCAGC-3Ј (626 -606), CAII forward primer: 5Ј-CTCTCAG-GACAATGCAGTGC-3Ј (216 -235), GAP reverse primer: 5Ј-CAAAGTTGTCATGGATGACC-3Ј (545-526), GAP forward primer: 5Ј-TGTCATCAA-CGGGAAGC-3Ј (239 -257).
Statistics
Differences between means were evaluated between groups in Figs. 2, 3, and 5, and 
Results

1,25(OH) 2 D 3 increased CA II mRNA expression in mixed marrow culture
The effect of 1,25(OH) 2 D 3 on expression of CA II mRNA in marrow cultures was studied by semiquantitative RT-PCR. Treatment with 10 nm 1,25(OH) 2 D 3 for 3 days beginning 24 h after plating mixed marrow cultures resulted in a 4.12 Ϯ 0.68-fold increase in CA II mRNA expression compared with control ( Fig. 1) . 1,25(OH) 2 D 3 did not change cell number: control cultures had equivalent number of cells (7.13 ϫ 10 5 /ml) as those treated with 10 nm 1,25(OH) 2 D 3 (6.93 ϫ 10 5 /ml). Figure 2A shows a representative phosphorimage of PCR products demonstrating a dose response to 1,25(OH) 2 D 3 . Figure 2B depicts pooled data from two separate experiments, demonstrating that the ED 50 for 1,25(OH) 2 D 3 stimulation of CA II was 0.25 nm. To better understand the mechanism of CA II induction, we looked at the time course of increased expression. In HL-60 cells, we had previously shown increased expression at 12 h, but maximal stimulation required at least 48 h treatment (4) . To determine the time course of CA II expression in this culture system, 10 nm 1,25(OH) 2 D 3 was added to cultures for 24, 48, or 72 h before RNA extraction on day 4 of culture. Figure 3 demonstrates that 1,25(OH) 2 D 3 had no effect on cells exposed for only 24 h and required a full 3 days exposure to see significant effects.
1,25(OH) 2 D 3 does not stimulate CA II mRNA expression in the absence of stromal cells
We next studied CA II in the absence of stromal elements. To deplete the marrow cultures of stromal elements, mixed marrow cells were plated overnight and the nonadherent FIG. 1. CA II mRNA expression in mixed marrow cultures. Mixed marrow cells were cultured for 4 days before total RNA extraction. 10 nM 1,25(OH) 2 D 3 was added 24 h after plating. Total RNA was subjected to RT-PCR for CA II or GAP in separate reactions using a 32 P-labeled forward primer to allow for visualization. PCR products were run on a 15% acrylamide gel and the gel exposed to a phosphorimager for quantitation. Densitometric readings expressed as CA II/GAP are normalized to control conditions. 1,25(OH) 2 D 3 treated cultures showed a 4.12 Ϯ 0.68-fold increase in CA II mRNA expression compared with control cultures, P Ͻ 0.05. The figures shows pooled data from seven separate experiments. fraction replated. These cells consist of monocytic precursors that exhibit 99% nonspecific esterase staining and are negative for alkaline phosphatase. Because these cells are of the monocytic lineage, they require MCSF for survival (14) . 2.5% L929 conditioned media was used as a source of MCSF to achieve a final concentration of 875 U/ml. Cultures of nonadherent marrow cells treated with 1,25(OH) 2 D 3 for 3 days did not show increased CA II expression and in fact showed a greater than 60% decrease in expression compared with control cultures (Fig. 4) .
To ensure that the nonadherent marrow cells were precursors capable of forming mature osteoclasts, the cells were plated on ST-2 cells that support osteoclast formation in coculture (15) . When the nonadherent marrow cells were plated on ST-2 cells in the presence of dexamethasone and 1,25(OH) 2 D 3 for 7 days, tartrate resistant acid phosphatase positive multinucleated cells (TRAP ϩ MNC) were formed, indicating that the nonadherent marrow cells contained osteoclast progenitors (data not shown). When these cells were plated on ST-2 cells for 4 days, 3 day treatment with 10 nm 1,25(OH) 2 D 3 stimulated CA II expression 22 Ϯ 3.6-fold (shown in the two left bars in Fig. 5 ), a significantly greater degree than that seen with primary cultures. ST-2 cells alone do not express CA II mRNA and do not form TRAPϩMNCs in our hands (data not shown) and in the laboratories of others (14, 15) .
Induction of CA II mRNA by 1,25(OH) 2 D 3 is not via a soluble factor
To determine whether the stromal cells induce CAII mRNA expression via a soluble factor, nonadherent marrow cells were treated with conditioned media. Two different sources of conditioned media were used: ST-2 culture media under conditions that induce CA II expression in coculture with nonadherent marrow cells (dexamethasone and (Fig. 5) . The increase was significantly less than that seen in coculture when cellular contact was maintained and was not significantly different than control.
PTH stimulates CA II mRNA expression in mixed cultures
We then asked if the CA II response was specific to 1,25(OH) 2 D 3 or could be evoked by other agents known to promote osteoclast differentiation. Mixed marrow cultures were treated with 10 nm 1,25(OH) 2 D 3 , 25 ng/ml PTH, or neither for 3 days. CA II expression was similarly stimulated approximately 4-fold by either 1,25(OH) 2 D 3 or PTH. Combined treatment did not cause an additive effect (Fig. 6 ).
Discussion
We demonstrate here that 1,25(OH) 2 Nonadherent marrow cells were cultured with 2.5% L929 conditioned media alone, 10 nM 1,25(OH) 2 D 3 , or 50% conditioned media as indicated. Four days after plating, total RNA was extracted and RT-PCR performed as previously described. As previously shown, 1,25(OH) 2 D 3 decreased CA II expression in these nonadherent cells, whereas conditioned media did not significantly affect CA II levels.
a P Ͻ 0.01 compared with control; b P Ͻ 0.05 compared with control cultures not treated with conditioned media. expression in monocytic precursors cultured in the absence of stromal cells. Therefore, our results suggest that CA II expression results from effects of differentiating agents on accessory stromal cells, creating a microenvironment that promotes osteoclast differentiation.
The necessity of stromal cells during osteoclast differentiation has been demonstrated by other investigators. The formation of mature osteoclast-like cells does not occur when hematopoietic precursors are separated from stromal cells by a membrane (10, (15) (16) (17) . Our results suggest that the accessory function of stromal cells begins at an early time point: mononuclear osteoclast progenitors are not induced to express CA II mRNA when separated from stromal cells. From these findings, it can be surmised that an unidentified factor presented by the stromal cell membrane influences monocytic entry into the osteoclastic differentiation pathway. A possible candidate is membrane bound MCSF, which is known to increase in response to 1,25(OH) 2 D 3 (12) and PTH (18) .
These findings contrast with the previously reported ability of 1,25(OH) 2 D 3 to directly induce CA II mRNA expression in the HL-60 or avian monomyelocytic cell lines (4 -6, 8) . As well, we have been unable to show an effect of PMA on CA II expression in primary marrow cultures (data not shown) despite our previously reported synergistic action of 1,25(OH) 2 D 3 and PMA on CA II expression in the HL-60 cell line (4). Thus, CA II expression in these cell lines does not adequately reflect the pattern of CA II expression by cells capable of becoming mature osteoclasts. In particular, in cultures with osteoclastogenic potential physical contact with stromal cells is required for induction of CA II expression. Because stromal cells are known to be required for osteoclast differentiation, we hypothesized that the increased CA II mRNA expression was a result of differentiation of the cell toward the osteoclast phenotype rather than a direct response to 1,25(OH) 2 D 3 . To investigate this question, we substituted PTH, which also induces osteoclastogenesis (19, 20) , in the role of differentiator. PTH also significantly increased CA II mRNA expression, indicating that the effect of either 1,25(OH) 2 (21) . Commitment to the macrophage phenotype should decrease CA II expression as this isozyme is not found in macrophages (5, 22) . In contrast, the previously reported ability of 1,25(OH) 2 D 3 to increase CA II expression in monomyelocytic cell lines (4 -6, 8) may be due to direct action on the CA II gene. A putative VDRE has been identified in the CA II gene (7), and it may be an effect on this cis element, which is responsible for the minimal increase in CA II expression seen in the transwell experiments in the presence of 1,25(OH) 2 The paradigm of interaction between stromal cells and osteoclast precursors or the mature osteoclast occurs throughout the culture period (24, 25) . Increased osteoclastogenesis resulting from estrogen deficiency, for instance, is due to effects on the stromal cells rather than osteoclast precursors. Estrogen decreases stromal cell production of the osteoclast promoting cytokine IL-6 (26) and estrogen can alter MCSF production by stromal cells (27) . Even in giant cell tumors of bone, an example of dysregulated osteoclast formation, this hierarchy is maintained: the giant osteoclasts arise due to stimulation from a neoplastic stromal cell (28) . The ability of both PTH and 1,25(OH) 2 D 3 to stimulate early CA II expression shown here, as well, depends on the physical presence of stromal cells. It has recently been shown that bone resorption by mature osteoclasts also requires the physical presence of stromal cells (29, 30) . These numerous examples illustrate that bone resorption, i.e. osteoclast recruitment and activity, is a process that cannot be disassociated from other cells within the bone environment.
In summary, our findings show that hematopoietic stem cell contact with bone marrow stromal cells is essential for the early entry of monocytic precursors into the osteoclast lineage. We provide further evidence that stromal membrane bound factors are critical to the differentiation and expression of osteoclast functional machinery such as CA II. These finding suggest that restriction of osteoclast formation and function to the bone marrow environment evolves from the symbiotic relationship between osteoclasts and bone stromal cells. 
